Antidepressants and pregnancy: Complexities of producing evidence-based information

CMAJ. Canadian Medical Association Journal

Volumn 182, Issue 10, 2010, Pages 1017-1018

  Einarson, Adrienne ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PAROXETINE; VENLAFAXINE;

CARDIOVASCULAR DEFECT; CARDIOVASCULAR DISEASE; DEPRESSION; DRUG SAFETY; EVIDENCE BASED PRACTICE; FETOMATERNAL TRANSFUSION; HUMAN; NOTE; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE LABOR; PRESCRIPTION; PREVALENCE; RISK ASSESSMENT; SPONTANEOUS ABORTION; TERATOGENICITY; ADULT; CHEMICALLY INDUCED; COMPLICATION; DEPRESSIVE DISORDER; EVIDENCE BASED MEDICINE; FEMALE; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROCEDURES; PSYCHOLOGY;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 77954603304     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.100507     Document Type: Note

References (9)

1. Muzik M, Marcus SM, Heringhausen JE et al. When depression complicates child-bearing: guidelines for screening and treatment during antenatal and postpartum obstetric care. Obstet Gynecol Clin North Am 2009;36:771-88.
2. Yonkers KA, Wisner KL, Stewart DE, et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists [review]. Obstet Gynecol 2009; 114:703-13.
3. Einarson TR, Einarson A. Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf 2005;14:823-7.
4. Tanne JH. GlaxoSmithKline told to pay family $2.5m after jury finds paroxetine caused son's heart defects. BMJ 2009;339:b4266.
5. Nakhai-Pour HR, Broy P, Bérard A . Antidepressant use during pregnancy and the risk of spontaneous abortion. CMAJ 2010;182:1031-7.
6. Bonari L, Koren G, Einarson TR, et al. Use of antidepressants by pregnant women: evaluation of perception of risk, efficacy of evidence based counseling and determinants of decision making. Arch Womens Ment Health 2005;8:214-20.
7. Hemminki E. Treatment of miscarriage: current practice and rationale. Obstet Gynecol 1998;91:247-53. (Pubitemid 28074156)
8. Regan L, Rai R. Epidemiology and the medical causes of miscarriage. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:839-54.
9. Einarson A, Choi J, Einarson TR, et al. Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. J Obstet Gynaecol Can 2009;31:452-6.